Literature DB >> 206698

Studies in the (+)-morphinan series. 5. Synthesis and biological properties of (+)-naloxone.

I Iijima, J Minamikawa, A E Jacobson, A Brossi, K C Rice.   

Abstract

(+)-Naloxone was prepared in 26% overall yield in eight steps from (+)-7-bromodihydrocodeinone dimethyl ketal by a synthesis which excluded enantiomeric contamination. (+)-Naloxone was examined in three assay systems and found to have no more than 1/1000(-1)/10 000th the activity of (-)-naloxone; it can, thus, serve to test the stereospecificity of the biochemical and pharmacological actions of (-)-naloxone.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 206698     DOI: 10.1021/jm00202a018

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  35 in total

Review 1.  Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.

Authors:  Mark R Hutchinson; Yehuda Shavit; Peter M Grace; Kenner C Rice; Steven F Maier; Linda R Watkins
Journal:  Pharmacol Rev       Date:  2011-07-13       Impact factor: 25.468

2.  Comparison of (+)- and (-)-Naloxone on the Acute Psychomotor-Stimulating Effects of Heroin, 6-Acetylmorphine, and Morphine in Mice.

Authors:  Guro Søe Eriksen; Jannike Mørch Andersen; Fernando Boix; Marianne Skov-Skov Bergh; Vigdis Vindenes; Kenner C Rice; Marilyn A Huestis; Jørg Mørland
Journal:  J Pharmacol Exp Ther       Date:  2016-06-08       Impact factor: 4.030

Review 3.  Neuropsychopharmacological understanding for therapeutic application of morphinans.

Authors:  Eun-Joo Shin; Jau-Shyong Hong; Hyoung-Chun Kim
Journal:  Arch Pharm Res       Date:  2010-10-30       Impact factor: 4.946

4.  In vitro evidence for the participation of intestinal opioids in the control of peristalsis in the guinea pig small intestine.

Authors:  W Kromer; W Pretzlaff
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-11       Impact factor: 3.000

5.  p38 mitogen-activated protein kinase inhibitor SB203580 reverses the antianalgesia induced by dextro-morphine or morphine in the mouse spinal cord.

Authors:  Hsiang-En Wu; Han-Sen Sun; Caleb W Cheng; Leon F Tseng
Journal:  Eur J Pharmacol       Date:  2006-09-08       Impact factor: 4.432

6.  (+)-Naloxone blocks Toll-like receptor 4 to ameliorate deleterious effects of stress on male mouse behaviors.

Authors:  Eva M Medina-Rodriguez; Kenner C Rice; Eléonore Beurel; Richard S Jope
Journal:  Brain Behav Immun       Date:  2020-08-26       Impact factor: 7.217

7.  Prevention of cocaine-induced hyperactivity by a naloxone isomer with no opiate antagonist activity.

Authors:  N Chatterjie; G J Alexander; J A Sechzer; K W Lieberman
Journal:  Neurochem Res       Date:  1996-06       Impact factor: 3.996

8.  Peristalsis in the isolated guinea-pig ileum during opiate withdrawal.

Authors:  W Kromer; R Woinoff
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-11       Impact factor: 3.000

9.  The opioid receptor antagonist, naloxone, protects spinal motor neurons in a murine model of alphavirus encephalomyelitis.

Authors:  Natalie A Prow; David N Irani
Journal:  Exp Neurol       Date:  2007-03-23       Impact factor: 5.330

10.  Synthesis and Characterization of a Novel Diels - Alder Adduct of Codeine.

Authors:  Christopher W Cunningham; Kellie Hom; Chayan Acharya; Angela Wilks; Alexander D Mackerell; Andrew Coop
Journal:  Helv Chim Acta       Date:  2010-02       Impact factor: 2.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.